5N Plus (OTCMKTS:FPLSF – Get Free Report) is one of 297 publicly-traded companies in the “Chemicals” industry, but how does it contrast to its competitors? We will compare 5N Plus to similar companies based on the strength of its dividends, institutional ownership, analyst recommendations, profitability, earnings, valuation and risk.
Valuation and Earnings
This table compares 5N Plus and its competitors revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| 5N Plus | $391.06 million | $50.57 million | 25.31 |
| 5N Plus Competitors | $6.35 billion | $216.27 million | -5.10 |
5N Plus’ competitors have higher revenue and earnings than 5N Plus. 5N Plus is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| 5N Plus | 14.14% | 26.36% | 11.28% |
| 5N Plus Competitors | -60.58% | -10.75% | -1.27% |
Insider and Institutional Ownership
0.1% of 5N Plus shares are owned by institutional investors. Comparatively, 47.6% of shares of all “Chemicals” companies are owned by institutional investors. 3.9% of 5N Plus shares are owned by insiders. Comparatively, 13.8% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for 5N Plus and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 5N Plus | 0 | 1 | 2 | 1 | 3.00 |
| 5N Plus Competitors | 3216 | 12223 | 14240 | 503 | 2.40 |
As a group, “Chemicals” companies have a potential upside of 11.79%. Given 5N Plus’ competitors higher probable upside, analysts plainly believe 5N Plus has less favorable growth aspects than its competitors.
Risk and Volatility
5N Plus has a beta of 1.86, suggesting that its share price is 86% more volatile than the S&P 500. Comparatively, 5N Plus’ competitors have a beta of 1.23, suggesting that their average share price is 23% more volatile than the S&P 500.
Summary
5N Plus beats its competitors on 8 of the 13 factors compared.
About 5N Plus
5N Plus Inc. produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells. It also provides active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial application markets. 5N Plus Inc. is headquartered in Montreal, Canada.
Receive News & Ratings for 5N Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 5N Plus and related companies with MarketBeat.com's FREE daily email newsletter.
